This SolarEdge Analyst Turns Bullish; Here Are Top 2 Upgrades For Wednesday
Wall Street analysts upgraded DTM, SEDG. Check out analyst ratings and price targets on Benzinga.
Read original at benzingaStocks · News reference
Nuvectis Pharma's Ciprocopan Receives Marketing Approval From National Medicinal Products Administration Of China To Treat Paroxysmal Nocturnal Hemoglobinuria
Nuvectis Pharma, Inc. (NASDAQ:NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 23, 2026, 11:31 AM
- Checked
- Jul 23, 2026, 11:31 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Top names on Wall Street have had their outlook changed by analysts, including downgrades and price target cuts. See what they think about EIX.
Read original at benzingaThis Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Consider ACMR stock: analysts' thoughts
Read original at benzingaThis Five Below Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed outlook on top names. See analyst ratings for VTEX, FIS, and more. FIS stock analysis also included.
Read original at benzinga